Ares Life Sciences is a private equity firm founded in 2008 with the backing of the Bertarelli family to invest in revenue generating life science companies. The firm focuses solely on the life sciences sector, in particular channeling investments into the pharmaceuticals, bio-technologies, medical technologies and healthcare services sectors in Europe. The firm focuses on companies with international growth potential, particularly in emerging markets, and strong intellectual property. The firm makes both growth and buyout investments primarily in Europe, taking a hands-on approach and requiring board seats in its portfolio companies. It provides value through both its organic growth and acquisition strategies.
Growth
1 funds found in our dataset.
Built for investment teams that need to move faster.
Intelligently process data room financials, generate auditable analyses, and export IC-ready deliverables.